Keywords

• SODIUM STEARYL FUMARATE;sodium octadecyl fumarate;SodiumStearylFumarate(Excipient)OpenPartDmf;Sodium
• Sodium octadecyl fumarate supplier manufacturer
• high purity 4070-80-8

Quick Details

• ProName: Sodium octadecyl fumarate
• CasNo: 4070-80-8
• Molecular Formula: C22H39NaO4
• Appearance: detailed see specifications
• Application: Pharmaceutical intermediates.etc
• PackAge: according to customer's requirement
• Purity: ≥99%
• Storage: Store in cool & dry place
• Transportation: as per your request
• LimitNum: 0

Superiority

1. Production capacity: we have three production base with high-tech production equipment and instruments, equipped with professional production personnel, meet your requirements.
2. Quality assurance: we have a first-class testing equipment and testing personnel, in strict accordance with ISO and cGMP standards, ensure that the quality of the shipment.
3.Ultra-low prices, we follow the meager profit but high turnover principle to win more customers, to provide you with quality and cheap products.
4.The best service: we can real-time quotation, tracking service, ensure the safety of the goods to the clients.
5. Customer groups: our clients throughout the world more than 30 countries, high quality products, low price, best service to win the customer's consistent high praise.
If you demand the product, you are welcome to contact us at any time, we guarantee that you seriously every inquiry, give you the fastest reply and the best service.

Details

Sodium octadecyl fumarate Basic information
Product Name:Sodium octadecyl fumarate
Synonyms:SODIUM STEARYL FUMARATE;sodium octadecyl fumarate;SodiumStearylFumarate(Excipient)OpenPartDmf;Sodium Stearyl Fumarate (Excipient);Monosodium stearyl fumarate;2-Butenedioic acid (2E)-, monooctadecyl ester, sodium salt;SODIUMSTEARYLFUMARATE,FCC;SODIUMSTEARYLFUMARATE,NF
CAS:4070-80-8
MF:C22H39NaO4
MW:390.53
EINECS:223-781-1
Product Categories:
Mol File:4070-80-8.mol
Sodium octadecyl fumarate Chemical Properties
Safety Information
Hazard Codes Xi
Risk Statements 36/38
Safety Statements 26